Page last updated: 2024-12-08

erythritol 4-phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

D-erythritol 4-phosphate : A tetritol phosphate consisting of D-erythritol having the phosphate at the 4-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID192838
CHEMBL ID3222164
CHEBI ID15770
SCHEMBL ID570977
MeSH IDM0218384

Synonyms (21)

Synonym
7183-41-7
CHEBI:15770 ,
(2r,3s)-2,3,4-trihydroxybutyl dihydrogen phosphate
4-o-phosphono-d-erythritol
d-erythritol 4-(dihydrogen phosphate)
l-erythritol 1-phosphate
d-erythritol 4-phosphate
C03494
1U0G
erythritol 4-phosphate
2,3,4-trihydroxybutyl dihydrogen phosphate
1,2,3,4-butanetetrol, 1-(dihydrogen phosphate), (s-(r*,s*))-
SCHEMBL570977
CHEMBL3222164
QRDCEYBRRFPBMZ-IUYQGCFVSA-N
erythritol-4-phosphate
AKOS030531179
DTXSID20992539
Q27098223
HY-141532
CS-0179690
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
alditol 4-phosphate
tetritol phosphate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1163711Inhibition of Escherichia coli IspD2014Journal of medicinal chemistry, Dec-11, Volume: 57, Issue:23
Development of inhibitors of the 2C-methyl-D-erythritol 4-phosphate (MEP) pathway enzymes as potential anti-infective agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's7 (36.84)29.6817
2010's9 (47.37)24.3611
2020's2 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.38

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.38 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.38)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (15.79%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (84.21%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]